Actively Recruiting

Phase 1
Age: 18Years +
All Genders
Healthy Volunteers
NCT07258836

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Led by Eli Lilly and Company · Updated on 2026-04-17

41

Participants Needed

6

Research Sites

53 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of the study is to check how safe and well-tolerated \[18F\]LY4214835 injection is in healthy participants and participants with cancer. The study drug will be administered intravenously (IV) (into a vein). Participation in the study will last approximately 35 days.

CONDITIONS

Official Title

A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • For cancer participants: Have a confirmed diagnosis of cancer by imaging, cytology, or histology
  • For cancer participants: Have not received systemic cancer therapy or have disease progression after standard treatment
  • For cancer participants: Have at least one tumor visible on imaging that is 15 millimeters or larger
  • For healthy participants: Be clinically healthy at screening and on the day of the PET imaging visit, confirmed by medical evaluation, vital signs, physical exam, lab tests, and ECG
  • Be 18 years of age or older
Not Eligible

You will not qualify if you...

  • Are pregnant or planning to become pregnant during the study
  • Are breastfeeding or planning to breastfeed during the study
  • Have a history of risk factors for Torsades de Pointes (such as heart failure, low potassium, or family history of Long QT Syndrome)
  • Are currently receiving cancer therapy or are between treatment cycles
  • Have a prolonged QT/corrected QT interval greater than 450 milliseconds on repeated tests

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

Invicro

New Haven, Connecticut, United States, 06510

Actively Recruiting

2

Boston Medical Center

Boston, Massachusetts, United States, 02118

Not Yet Recruiting

3

Massachusetts General Hospital (MGH)

Charlestown, Massachusetts, United States, 02129

Not Yet Recruiting

4

BAMF Health Inc.

Grand Rapids, Michigan, United States, 49503

Not Yet Recruiting

5

Memorial Sloan Kettering Cancer Center

New York, New York, United States, 10065

Not Yet Recruiting

6

Ichor Research

Syracuse, New York, United States, 13210

Not Yet Recruiting

Loading map...

Research Team

T

Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or

CONTACT

P

Physicians interested in becoming principal investigators please contact

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here